Cost Limitations on Biological Treatments for Immune Diseases

Cost Restrictions on Biologic Therapy for Autoimmune Diseases in Germany

What are Biologics? Biologics are lab-engineered antibodies or proteins targeting the immune system, used for:

• Rheumatoid arthritis

• Psoriasis

• Crohn’s disease

• Ulcerative colitis

• Lupus erythematosus

Why are there restrictions?

• High cost: €15,000–30,000 per patient annually

• Cheaper alternatives: conventional therapy must be tried first

• G-BA guidelines: require disease severity, failure of other drugs, documented clinical evidence

Approval Process

1. Specialist physician report with justification

2. Submission to health insurance for review

3. Approval/denial, usually temporary (6–12 months)

4. Proof of effectiveness via regular medical reports

When is Biologic Therapy Denied?

• Other therapies not exhausted

• No clear medical evidence

• Insufficient physician justification

• Cheaper biosimilar available but not used

Patient Tips

• Request detailed medical report (diagnosis, failed drugs, side effects)

• Ask about biosimilars

• If denied: file objection (Widerspruch) within 4 weeks

• Seek support from patient associations (e.g., Rheuma-Liga)